Rating Change
Pivotal Research reiterated its Buy rating on AXS SPAC and New Issue ETF (NASDAQ:SPCX) on October 22, 2026.
Pivotal Research reiterated its Buy rating on AXS SPAC and New Issue ETF (NASDAQ:SPCX) on October 22, 2026.

At publication ·
AXS SPAC and New Issue ETF (NASDAQ:SPCX) · reiterate
At a glance
Pivotal Research reiterated its Buy rating on AXS SPAC and New Issue ETF (NASDAQ:SPCX) on October 22, 2026.
AXS SPAC and New Issue ETF operates in the Financial Services sector. The stock currently trades at $159.31 with a market capitalization of $8.9M.
Analyst coverage from Pivotal Research provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for AXS SPAC and New Issue ETF.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 22, 2026 | Pivotal Research | Buy | N/A |
| Oct 21, 2026 | JP Morgan | Overweight | N/A |
| Oct 21, 2026 | Barclays | Overweight | N/A |
| Oct 21, 2026 | Citigroup | Buy | N/A |
| Oct 21, 2026 | UBS | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View SPCX Stock Page
A rating of Buy from Pivotal Research reflects the analyst's outlook on AXS SPAC and New Issue ETF (NASDAQ:SPCX). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the SPCX forecast page.
Current market data
NASDAQ · SPCX
$159.31
Up: +$11.52 · +7.79%
Live quote updated
Keep reading
institutional ·
analyst ·
earnings ·
analyst ·